Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jad Chahoud

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Urologic Oncology|October 10, 2020
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicityAli Hajiran, Logan Zemp, Ahmet M Aydin, et al.
World Journal of Urology|June 6, 2025
Outcomes of PeIN at the surgical margin: insights from an organ-sparing penile cancer databaseSeyed Behzad Jazayeri, Adnan Fazili, R Barry Sirard, et al.
Cancers|September 27, 2025
Evaluating the Evolving Treatment Landscape of Systemic Therapies in Penile CancerSalvador Jaime-Casas, Regina Barragan-Carrillo, Federico Eskenazi, et al.
Current Oncology Reports|August 23, 2024
Correction to: Current Status and Challenges in Rare Genitourinary Cancer Research and Future DirectionsAntonio Cigliola, Gagan Prakash, Roger Li, et al.
Nature Reviews. Urology|August 20, 2020
Understanding genomics and the immune environment of penile cancer to improve therapyAhmet Murat Aydin, Jad Chahoud, Jacob J Adashek, et al.
Current Oncology Reports|June 7, 2024
Current Status and Challenges in Rare Genitourinary Cancer Research and Future DirectionsAntonio Cigliola, Gagan Prakash, Roger Li, et al.
Cancers|September 13, 2025
Current Role and Future Frontiers of Spatial Transcriptomics in Genitourinary CancersFiras Hatoum, Adnan Fazili, Justin W Miller, et al.
Frontiers in Oncology|January 11, 2021
Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to PembrolizumabJad Chahoud, William Paul Skelton, Philippe E Spiess, et al.
Cells|August 26, 2022
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell CarcinomaYumeng Zhang, Premsai Kumar, Jacob J Adashek, et al.
World Journal of Urology|September 16, 2020
Evaluation, diagnosis and surveillance of renal masses in the setting of VHL diseaseJad Chahoud, Melissa McGettigan, Nainesh Parikh, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Urologic Oncology|October 10, 2020
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicityAli Hajiran, Logan Zemp, Ahmet M Aydin, et al.
World Journal of Urology|June 6, 2025
Outcomes of PeIN at the surgical margin: insights from an organ-sparing penile cancer databaseSeyed Behzad Jazayeri, Adnan Fazili, R Barry Sirard, et al.
Cancers|September 27, 2025
Evaluating the Evolving Treatment Landscape of Systemic Therapies in Penile CancerSalvador Jaime-Casas, Regina Barragan-Carrillo, Federico Eskenazi, et al.
Current Oncology Reports|August 23, 2024
Correction to: Current Status and Challenges in Rare Genitourinary Cancer Research and Future DirectionsAntonio Cigliola, Gagan Prakash, Roger Li, et al.
Nature Reviews. Urology|August 20, 2020
Understanding genomics and the immune environment of penile cancer to improve therapyAhmet Murat Aydin, Jad Chahoud, Jacob J Adashek, et al.
Current Oncology Reports|June 7, 2024
Current Status and Challenges in Rare Genitourinary Cancer Research and Future DirectionsAntonio Cigliola, Gagan Prakash, Roger Li, et al.
Cancers|September 13, 2025
Current Role and Future Frontiers of Spatial Transcriptomics in Genitourinary CancersFiras Hatoum, Adnan Fazili, Justin W Miller, et al.
Frontiers in Oncology|January 11, 2021
Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to PembrolizumabJad Chahoud, William Paul Skelton, Philippe E Spiess, et al.
Cells|August 26, 2022
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell CarcinomaYumeng Zhang, Premsai Kumar, Jacob J Adashek, et al.
World Journal of Urology|September 16, 2020
Evaluation, diagnosis and surveillance of renal masses in the setting of VHL diseaseJad Chahoud, Melissa McGettigan, Nainesh Parikh, et al.
Pageof 12